Laxminarayana Kurady Bairy, Shakta Mani Satyam, Prakashchandra Shetty
Laxminarayana Kurady Bairy1, Shakta Mani Satyam2*, Prakashchandra Shetty3
1Dean and Chairperson- Pharmacology, RAK College of Medical Sciences, RAK Medical and Health Sciences University, Ras Al-Khaimah (UAE).
2Assistant Professor, Department of Pharmacology, Melaka Manipal Medical College (Manipal Campus), Manipal Academy of Higher Education, Manipal-576104, Karnataka (India).
3Associate Professor, Department of Anatomy, Melaka Manipal Medical College (Manipal Campus), Manipal Academy of Higher Education, Manipal-576104, Karnataka (India).
Volume - 13,
Issue - 12,
Year - 2020
Nowadays influence of gender and obesity on pain perception have been received substantial pragmatic attention. This may have implications for pain management among individuals. This systematic review was aimed to analyse the impact of gender and obesity on pain perception. The electronic databases of the Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, and EMBASE were searched using combinations of terms for gender, sex hormones, obese, body mass index, leptin, analgesic requirements, endogenous opioids, pain measurement, and pain perception/sensitivity/threshold. Studies without comparison as well as cross-sectional studies, case series, and case reports were excluded. In the context of summary of results of extensive literature search, we found that pain sensitivity against noxious stimuli is more experienced in obese as well as females whereas it is less experienced in lean as well as males. We also found that sex hormones have influence on leptin levels whereas leptin do not affect the level of sex hormones. This review reveals that from gender perspective sex hormones and from obesity perspective leptin play an important interlinked role in pain modulation. Gender and body mass index specific tailoring of pain treatments might become a conceivable outcome in the foreseeable future.
Cite this article:
Laxminarayana Kurady Bairy, Shakta Mani Satyam, Prakashchandra Shetty. An Insight on pain modulation with Gender and Obesity: A Systematic Review. Research J. Pharm. and Tech. 2020; 13(12):6284-6290. doi: 10.5958/0974-360X.2020.01093.8
1. McBeth J, Jones K. Epidemiology of chronic musculoskeletal pain. Best Pract Res Clin Rheumatol 2007;21(3):403-425.
2. International Association for the Study of Pain. IASP taxonomy. http://www.iasppain.org/Taxonomy?&navItemNumber=576. Updated October 20, 2014.
3. Nasir M, Parveen RA, Alam NN. Pattern of Analgesic Use in Post-Operative Pain Management in a Tertiary Level Teaching Hospital in Bangladesh. Research Journal of Pharmacy and Technology. 2016; 9(5): 493-496.
4. Mewada PS, Patel CK, Rami CS, Patel HU, Patel CN. New Emerging Targets for Obesity. Asian Journal of Research in Chemistry. 2010; 3(2): 278-287.
5. Amin SS. Obesity Prevalence in Primary School Children in Baghdad City. Research Journal of Pharmacy and Technology. 2019;12(1): 339-41.
6. Nadar S. Side effects of Obesity-A Review. Research Journal of Pharmacy and Technology 2015;8(8):979-986.
7. Reshmi B, Sethu G. A Study on Obesity among Children. Research Journal of Pharmacy and Technology. 2015;8(8):1177-1178.
8. Baheerati MM, Devi RG. Obesity in relation to Infertility. Research Journal of Pharmacy and Technology 2018;11(7):3183-3185.
9. Mohsen H, Shaden H, Faiza AL, Taghrid H. Correlation of serum leptin levels with insulin resistance in Syrian obese patients with type 2 diabetes mellitus. Research Journal of Pharmacy and Technology. 2013; 6(10): 1149-1151.
10. Mohan M. The Role of Leptin on Obesity: A Review. Research Journal of Pharmacy and Technology. 2014;7(12):1501-1505.
11. Monalisa R. Role of leptin in obesity. Research Journal of Pharmacy and Technology. 2015;8(8):1073-1076.
12. Al-Ogaidi SO, Abdulsattar SA, Al-Dulaimi HM. The Impact of Serum Leptin, Leptin Receptor and Insulin on Maternal Obesity. Research Journal of Pharmacy and Technology. 2019;12(7):3569-3574.
13. Fillingim RB. Sex differences in analgesic responses: evidence from experimental models. Eur J Anaesthesiol. 2002;19(Suppl. 26):16-24.
14. Isacson D, Bingefors K. Epidemiology of analgesic use: a gender perspective. Eur J Anaesthesiol 2002;19(Suppl. 26):5-15.
15. Starowicz K, Przewlocka B. The role of melanocortins and their receptors in inflammatory processes, nerve regeneration and nociception. Journal of Life Sciences. 2003;73:823-847.
16. Priyanka V, Rekha V. Analgesic, anti-inflammatory and antipyretic activity of Cissus quadrangularis. Journal of Pharmaceutical Science and Technology 2010;2(1):111-118.
17. Maria TC, Cenzo C, Valentina O, Micaela M, Omar C. Synthesis of ibuprofen heterocyclic amides and investigation of their analgesic and toxicological properties. European Journal of Medicinal Chemistry. 2003;38:513-518.
18. Bicer F, Eti Z, Aricioglu F, Konya D, Gogus Y. The effects of gabapentin, tramadol and amitriptyline on pain behavior in a rat neuropathic pain model: 14AP10-2. European Journal of Anaesthesiology 2010;27(47):217.
19. Kvachadze I, Tsagareli MG, Dumbadze Z. An overview of ethnic and gender differences in pain sensation. 2015;238:102-108.
20. Rovner GS, Sunnerhagen KS, Bjorkdahl A, Gerdle B, Borsbo B, Johansson F et al. Chronic pain and sex-differences; women accept and move, while men feel blue. PLoS One. 2017;12(4):e0175737 (online).
21. Eltumi HG, Tashani OA. Effect of Age, Sex and Gender on Pain Sensitivity: A Narrative Review. The Open Pain Journal. 2017;10:44-55.
22. Sorge RE, Mapplebeck JC, Rosen S, Beggs S, Tayes S, Alexander JK et al. Different immune cells mediate mechanical pain hypersensitivity in male and female mice. Nat Neurosci. 2015; 18(8): 1081-1083.
23. Feijo LM, Tarman GZ, Fontaine C, Harrison R, Johnstone T, Salomons T. Sex-specific effects of gender identification on pain study recruitment. The Journal of Pain. 2018;19(2):178-185.
24. Manubay J, Davidson J, Vosburg S, Jones J, Comer S, Sullivan M. Sex differences among opioid-abusing chronic pain patients in a clinical trial. J Addict Med. 2015;9(1):46-52.
25. Koons AL, Greenberg MR, Cannon RD, Beauchamp GA. Women and the experience of pain and opioid use disorder: A literature-based commentary. Clinical Therapeutics. 2018;40(2):190-196.
26. Riley JL, Robinson ME, Wise EA, Myers CD, Fillingim RB. Sex differences in the perception of noxious experimental stimuli: A meta-analysis. Pain. 1998;74:181-187.
27. Rosseland LA, Stubhaug A. Gender is a confounding factor in pain trials: Women report more pain than men after arthroscopic surgery. Pain 2004;112:248-253.
28. Gear RW, Miaskowski C, Gordon NC, Paul SM, Heller PH, Levine JD. Kappaopioids produce significantly greater analgesia in women than in men. Nat Med. 1996;2:1248-1250.
29. Gear RW, Gordon NC, Heller PH, Paul S, Miaskowski C, Levine JD. Gender difference in analgesic response to the kappa-opioid pentazocine. Neurosci Lett. 1996;205(3):207-209.
30. Cepeda MS, Carr DB. Women experience more pain and require more morphine than men to achieve a similar degree of analgesia. Anesth Analg. 2003;97:1464-1468.
31. Aubrun F, Salvi N, Coriat P, Riou B. Sex and age related differences in morphine requirements for postoperative pain relief. Anesthesiology. 2005; 103: 156-160.
32. Walkers JS, Carmody JJ. Experimental pain in healthy human subjects: Gender differences in nociception and in response to ibuprofen. Anesth Analg. 1998; 86: 1257-1262.
33. Zammataro M, Merlo S, Barresi M, Parenti C, Hu H, Sortino MA et al. Chronic treatment with fluoxetine induces sex-dependent analgesic effects and modulates HDAC2 and MGLU2 expression in female mice. Front. Pharmacol. 2017;8:743 (online).
34. Cruz WS, Pereira LA, Cezar LC, Camarini R, Felicio LF, Bernardi MM. Role of steroid hormones and morphine treatment in the modulation of opioid receptor gene expression in brain structures in the female rat. Springer Plus. 2015;4:355 (online).
35. Hussain AM, Khan FA, Ahmed A, Chawla T, Azam SI. Effect of gender on pain perception and analgesic consumption in laparoscopic cholecystectomy: An observational study. J Anaesthesiol Clin Pharmacol. 2013;29(3):337-341.
36. Chia YY, Chow LH, Hung CC, Liu K, Ger LP, Wang PN. Gender and pain upon movement are associated with the requirements for postoperative patient controlled iv analgesia: A prospective survey of 2,298 Chinese patients. Can J Anaesth. 2002;49:249-255.
37. Mattila K, Toivonen J, Janhunen L, Rosenberg PH, Hynynen M. Post-discharge symptoms after ambulatory surgery: First week incidence, intensity, and risk factors. Anesth Analg. 2005;101:1643-1650.
38. Taenzer AH, Clark C, Curry CS. Gender affects report of pain and function after arthroscopic anterior cruciate ligament reconstruction. Anesthesiology. 2000; 93: 670-675.
39. Lau H, Patil NG. Acute pain after endoscopic totally extraperitoneal (TEP) inguinal hernioplasty: Multivariate analysis of predictive factors. Surg Endosc. 2004;18:92-96.
40. Palmeira CC, Ashmawi HA, Posso Ide P. Sex and Pain Perception and Analgesia. Rev Bras Anestesiol. 2011;61:6:814-828.
41. Tousignant-Laflamme Y, Marchand S. Excitatory and inhibitory pain mechanisms during the menstrual cycle in healthy women. Pain. 2009; 146:47
42. Fillingim RB, Gear RW. Sex differences in opioid analgesia: clinical and experimental findings. Eur J Pain. 2004;8:413-425.
43. Gaumond I, Arsenault P, Marchand S. Specificity of female and male sex hormones on excitatory and inhibitory phases of formalin-induced nociceptive responses. Brain Res. 2005;1052:105-111.
44. Thompson AD, Angelotti T, Nag S, Mokha SS. Sex-specific modulation of spinal nociception by alpha-adrenoceptors: differential regulation by estrogen and testosterone. Neuroscience. 2008; 153: 1268-1277.
45. Hagiwara H, Kimura F, Mitsushima D, Funabashi T. Formalin-induced nociceptive behavior and c-Fos expression in middle-aged female rats. Physiol Behav. 2010;100:101-104.
46. Berkley KJ. Sex differences in pain. Behav Brain Sci. 1997;20:371-380.
47. Hurley RW, Adams MCB. Sex, gender and pain: an overview of a complex field. Anesth Analg. 2008;107:309-317.
48. Zubieta JK, Smith YR, Bueller JA, Xu Y, Kilbourn MR, Jewett DM et al. Muopioid receptor-mediated antinociceptive responses differ in men and women. J Neurosci. 2002;22:5100-5107.
49. Zubieta JK, Dannals RF, Frost JJ. Gender and age influences on human brain mu-opioid receptor binding measured by PET. Am J Psychiatry. 1999;156:842-848.
50. Cicero TJ, Nock B, O’Connor L, Meyer ER. Role of steroids in sex differences in morphine-induced analgesia: activational and organizational effects. J Pharmacol Exp Ther. 2002;300:695-701.
51. Wiesenfeld-Hallin Z. Sex differences in pain perception. Gender Med. 2005; 2:137-145.
52. Fillingim RB, King CD, Ribeiro-Dasilva MC, Rahim-Williams B, Riley JL. Sex, gender, and pain: a review of recent clinical and experimental findings. J Pain. 2009;10:447–85.
53. Gerdle B, Bjork J, Coster L, Henriksson K, Henriksson C, Bengtsson A. Prevalence of widespread pain and associations with work status: a population study. BMC Musculoskeletal Disorders. 2008;9:102-106.
54. Mogil JS. Sex differences in pain and pain inhibition: multiple explanations of a controversial phenomenon. Nat Rev Neurosci. 2012;13:859-66.
55. Craft RM. Modulation of pain by estrogens. Pain. 2007;132:S3–S12.
56. Craft RM, Mogil JS, Aloisi AM. Sex differences in pain and analgesia: the role of gonadal hormones. Eur J Pain. 2004;8:397-411.
57. Smith YR, Stohler CS, Nichols TE, Bueller JA, Koeppe RA, Zubieta JK. Pronociceptive and antinociceptive effects of estradiol through endogenous opioid neurotransmission in women. J Neurosci. 2006; 26: 5777-5785.
58. Cairns BE, Gazerani P. Sex-related differences in pain. Maturitas. 2009; 63: 292-296.
59. Claiborne J, Nag S, Mokha SS. Activation of opioid receptor like-1 receptor in the spinal cord produces sex-specific antinociception in the rat: estrogen attenuates antinociception in the female, whereas testosterone is required for the expression of antinociception in the male. The Journal of Neuroscience. 2006; 26(50): 13048-13053.
60. Ting-Ting Z, Zhen L, Ying-Li L, Jing-Jing Z, Dian-Wu L, Qing-Bao T. Obesity as a risk factor for low back pain: A meta-analysis. Clinical Spine. Surgery. 2018;31(1):22-27.
61. Okifuji A, Hare BD. The association between chronic pain and obesity. Journal of Pain Research 2015;8:399-408.
62. Song Z, Xie W, Chen S, Strong JA, Print MS, Wang JI et al. High-fat diet increases pain behaviors in rats with or without obesity. Scientific Reports. 2017;7(1):10350.
63. Tashani OA, Astita R, Sharp D, Johnson MI. Body mass index and distribution of body fat can influence sensory detection and pain sensitivity. Eur J Pain. 2017;21(7):1186-1196.
64. Younger J, Kapphahn K, Brennan K, Sullivan SD, Stefanick ML. Association of leptin with body pain in women. J Women’s Health (Larchmt). 2016;25(7):752-760.
65. Lloret LC, Decleves X, Oppert JM, Basdevant A, Clement K, Bardin C et al. Pharmacology of morphine in obese patients: clinical implications. Clin Pharmacokinet. 2009;48:635-651.
66. Mc Kendall MJ, Haier RJ. Pain sensitivity and obesity. Psychiatry Research. 1983;8:119-125.
67. Roane DS, Porter JR. Nociception and opioid-induced analgesia in lean (Fa/-) and obese (fa/fa) Zucker rats. Physiology Behavior. 1986; 38: 215-218.
68. Higgins DM, Kerns RD, Brandt CA, Haskell SG, Bathulapalli H, Gilliam W et al. Persistent pain and comorbidity among operation enduring freedom/operation Iraqi freedom/operation New Dawn veterans. Pain Med. 2014;15(5):782-790.
69. Deere KC, Clinch J, Holliday K, McBeth J, Crawley EM, Sayers A et al. Obesity is a risk factor for musculoskeletal pain in adolescents: findings from a population-based cohort. Pain. 2012; 153(9): 1932-1938.
70. Hoftun GB, Romundstad PR, Rygg M. Factors associated with adolescent chronic non-specific pain, chronic multisite pain, and chronic pain with high disability: The Young-HUNT Study. 2008. J Pain. 2012;13(9):874-883.
71. Smith SM, Sumar B, Dixon KA. Musculoskeletal pain in overweight and obese children. Int J Obes (Lond). 2014;38(1):11-15.
72. Hitt HC, McMillen RC, Thornton-Neaves T, Koch K, Cosby AG. Comorbidity of obesity and pain in a general population: results from the Southern Pain Prevalence Study. J Pain. 2007;8(5):430-436.
73. Miscio G, Guastamacchia G, Brunani A, Priano L, Baudo S, Mauro A. Obesity and peripheral neuropathy risk: a dangerous liaison. J Peripher Nerv Syst. 2005;10:354-358.
74. Ramzan I, Wong BK, Corcaron BG. Pain sensitivity in dietary-induced obese rats. Physiology Behavior. 1993;54: 433-445.
75. Ensari G, Gumustekin M, Ates M. Possible involvement of ghrelin on pain threshold in obesity. Medical Hypotheses. 2010;74:452-464.
76. Zahorska-Markiewicz B, Zych P, Kucio C. Pain sensitivity in obesity. Acta Physiol Pol. 1988;39:183-187.
77. Pradalier A, Dry J, Willer JC, Boureau F. Obesite et baisse du seuil nociceptif. Pathol Biol. 1980;28: 462-474.
78. Khimich S. Level of sensitivity of pain in patients with obesity. Acta Chir Hung. 1997;36:166-177.
79. Raymond NC, de Zwaan M, Faris PL, Nugent SM, Achard DM, Crosby RD et al. Pain thresholds in obese binge-eating disorder subjects. Biol Psychiatry. 1995;37:202-214.
80. Maffiuletti NA, Morelli A, Martin A, Duclay J, Billot M, Jubeau M et al. Effects of gender and obesity on electrical current thresholds. Muscle Nerve. 2011;44:202-207.
81. Dodet P, Perrot S, Auvergne L, Hajj A, Simoneau G, Decleves X et al. Sensory impairment in obese patients? Sensitivity and pain detection thresholds for electrical stimulation after surgery-induced weight loss, and comparison with a non-obese population. Clin J Pain. 2013; 29(1): 43-49.
82. Nordander C, Willnerr J, Hansson GA, Larsson B, Unge J, Granguist L et al. Influence of subcutaneous fat layer, as measured by ultasound, skinfold calipers and BMI, on the EMG amplitude. Eur J Appl Physiol. 2003;89:514-519.
83. Clinical Guidelines in the identification, evaluation and treatment of overweight and obesity in adults, the evidence report, national institutes of health. Obes Res. 1998;6(suppl 2):51S-209S.
84. Allison, D.B., Fontaine, K.R., Manson, J.E., Stevens, J.,Vanitalie, T.B. Annual deaths attributable to obesity in the United states. JAMA. 1999; 282: 1530-1538.
85. World Health Organization. Obesity and overweight. Available at: http://www.who.int/dietphysicalactivity/publications/facts/obesity/en/.2010
86. Lim G, Wang S, Zhang Y, Tian Y, Mao J. Spinal leptin contributes to the pathogenesis of neuropathic pain in rodents. J Clin Invest. 2009;119:295-304.
87. Maeda T, Kiguchi N, Kobayashi Y, Ikuta T, Ozaki M, Kishioka S. Leptin derived from adipocytes in injured peripheral nerves facilitates development of neuropathic pain via macrophage stimulation. Proc Natl Acad Sci USA. 2009;106:13076-13081.
88. Selim K, Sinan C, Suleyman S, Mete O, Mustafa S, Haluk K. Effects of central and peripheral administration of leptin on pain threshold in rats and mice. Neuroendocrinology Lett. 2003;24:193-196.
89. Dunbar JC, Lu H. Leptin-induced increase in sympathetic nervous and cardiovascular tone is mediated by proopiomelanocortin (POMC) products. Brain Res Bull. 1999;50:215-221.
90. Rene F, Muller A, Jover E, Kieffer B, Koch B, Loeffler JP. Melanocortin receptors and delta-opioid receptor mediateopposite signalling actions of POMC derived peptides in CATH cells. European Journal of Neuroscience. 1998;10(5):1885-1894.
91. Vrinten DH, Kalkman CJ, Adan RA, Gispen WH. Neuropathic pain: a possible role for the melanocortin system? European Journal of Pharmacology. 2001; 429:61-69.
92. Yinghong T, Shuxing W, Yuxin M, Grewo L, Hyangin K, Jianren M. Leptin enhances NMDA-induced spinal excitation in rats: A functional link between adipocytokine and neuropathic pain. Journal of Pain. 2011;152:1263–1271.
93. D’Mello R, Dickenson AH. Spinal cord mechanisms of pain. Br J Anaesth. 2008;101:8-16.
94. Doubell TP, Mannion RJ, Woolf CJ. The dorsal horn: state-dependent sensory processing, plasticity and the generation of pain. In: Wall PD, Melzack R, editors. Textbook of pain. Fourth edition. London: Churchill Livingstone. 1999. p. 165-181.
95. Petrenko AB, Yamakura T, Baba H, Shimoji K. The role of N-methyl-D-aspartate (NMDA) receptors in pain: a review. Anesth Analg. 2003;97:1108-1116.
96. Dubner R. Neuronal plasticity and pain following peripheral tissue inflammation or nerve injury. In: Bond M, Charlton E, Woolf CJ, editors. Pain research and clinical management. Proc. Vth World Congress on Pain, vol.5. Amsterdam: Elsevier; 1991. p. 263-276.
97. Mao J, Price DD, Hayes RL, Lu J, Mayer DJ. Differential roles of NMDA and non-NMDA receptor activation in induction and maintenance of thermal hyperalgesia in rats with painful peripheral neuropathy. Brain Res. 1992;598:271-278.
98. Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet. 1999;353:1959–1964.
99. Fisher K, Coderre TJ, Hagen NA. Targeting N-methyl-D-aspartate receptor for chronic pain management: preclinical animal studies, recent clinical experience and future research directions. J Pain Symptom Manage. 2000;20:358-373.
100. Hewitt DJ. The use of NMDA-receptor antagonists in the treatment of chronic pain. Clin J Pain 2000;16:S73-S79.
101. Rosenbaum M, Nicolson M, Hirsch J, Heymsfield SB, Gallagher D, Chu F et al. Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab. 1996; 81: 3424-3427.
102. Hickey MS, Israel RG, Gardiner SN, Considine RV, McCammon MR, Tyndall GL et al. Gender differences in serum leptin levels in humans. Biochem Mol Med. 1996;59:1-6.
103. Kennedy A, Gettys TW, Watson P, Wallace P, Ganaway E, Pan Q et al. The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. J Clin Endocrinol Metab. 1997;82:1293-1300.
104. Bhasin S, Storer TW, Berman N, Yarasheski KE, Clevenger B, Phillips J et al. Testosterone replacement increases fat-free mass and muscle size in hypogonadal men. J Clin Endocrinol Metab. 1997;82 (2):407-413.
105. Arslanian S, Suprasongsin C. Testosterone treatment in adolescents with delayed puberty: changes in body composition, protein, fat, and glucose metabolism. J Clin Endocrinol Metab. 1997;82:3213-3220.
106. Karim R, Stanczyk FZ, Brinton RD, Rettberg J, Hodis HN, Mack WJ. Association of endogenous sex hormones with adipokines and ghrelin in postmenopausal women. J Clin Endocrinol Metab. 2015; 100(2): 508-515.
107. Considine RV, Sinha MK, Heiman ML, Kriauciunas, Stephens TW, Nyce MR et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. New England Journal of Medicine. 1996; 334: 292-295.
108. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Yet al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Medicine. 1995;1:1155-1161.
109. Vettor R, Vicennati V, Gambineri A, Pagano C, Calzoni F, Pasquali R. Leptin and the hypothalamic-pituitary-adrenal axis activity in women with different obesity phenotypes. International Journal of Obesity. 1997;21:708-711.
110. Ramachandran A, Snehalatha C, Vijay V, Satyavani K, Latha E, Haffner S. Plasma leptin in non-diabetic Asian Indians: association with abdominal adiposity. Diabetic Medicine. 1997;14:937-941.
111. Wauters M, Mertens I, Considine R, Leeuw ID, Van Gaal L. Are leptin levels dependent on body fat distribution in obese men and women? Eating and Weight Disorders. 1998;3:124-130.
112. Hube F, Lietz U, Igel M, Jensen PB, Tornqvist H, Joost HG et al. Difference in leptin mRNA levels between omental and subcutaneous abdominal adipose tissue from obese humans. Hormone and Metabolic Research. 1996;28:690-693.
113. Montague CT, Prins JB, Sanders L, Digby JE, O’Rahilly S. Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution. Diabetes. 1997; 46(3): 342-347.
114. Lefebvre AM, Laville M, Vega N, Riou JP, van Gaal L, Auwerx J et al. Depotspecific differences in adipose tissue gene expression in lean and obese subjects. Diabetes. 1998;47:98-103.
115. Casabiell X, Pineiro V, Peino R, Lage M, Camina J, Gallego R et al. Gender differences in both spontaneous and stimulated leptin secretion by human omental adipose tissue in vitro: dexamethasone and estradiol stimulate leptin release in women, but not in men. Journal of Clinical Endocrinology and Metabolism. 1998;83:2149-2155.
116. Schwartz M, Peskind E, Raskind M, Boyko EJ, Porte D. Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nature Medicine. 1996;2:589-593.
117. Sivan E, Whittaker P, Sinha D, Homko CJ, Lin M, Reece EA et al. Leptin in human pregnancy: the relationship with gestational hormones. American Journal of Obstetrics and Gynecology. 1998; 179: 1128-1132.
118. Kristensen K, Pedersen SB, Richelsen B. Regulation of leptin by steroid hormones in rat adipose tissue. Biochemical and Biophysical Research Communications. 1999;259:624-630.
119. Lahlou N, Landais P, De Boissieu D, Bougneres PF. Circulating leptin in normal children and during the dynamic phase of juvenile obesity, relation to body fatness, energy metabolism, caloric intake, and sexual dimorphism. Diabetes. 1997; 46: 989-993.
120. Shimizu H, Shimomura Y, Nakanishi Y, Futawatari T, Ohtani K, Sato N et al. Estrogen increases in vivo leptin production in ratsand human subjects. Journal of Endocrinology. 1997;154:285-292.
121. Chebab FF, Mounzih K, Lu R, Lim ME. Early onset of reproductive function in normal female mice treated with leptin. Science. 1997; 275: 88-90.
122. Chehab FF, Lim ME, Lu R. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat Genet. 1996;12:318-320.
123. Wabitsch M, Blum WF, Muche R, Braun M, Hube F, Rascher W et al. Contribution of androgens to the gender difference in leptin production in obese children and adolescents. Journal of Clinical Investigation. 1997;100(4):808-813.
124. Wu-Peng S, Rosenbaum M, Nicolson M, Chua SC, Leibel RL. Effects of exogenous gonadal steroids on leptin homeostasis in rats. Obesity Research. 1999;7:586-592.
125. Hislop M, Ratanjee B, Soule S, Marais A. Effects of anabolic androgenic steroid use or gonadal testosterone suppression on serum leptin concentration in men. European Journal of Endocrinology. 1999;141:40-46.
126. Palmert MR, Radovick S, Boepple PA. The impact of reversible gonadal sex steroid suppression on serum leptin concentrations in children with central precocious puberty. Journal of Clinical Endocrinology and Metabolism. 1998;83:1091-1096.
127. Behre HM, Simoni M, Nieschlag E. Strong association between serum levels of leptin and testosterone in men. Clinical Endocrinology. 1997;47:237-240.
128. Jockenhovel F, Blum WF, Vogel E, Englaro P, Muller-Wieland D, Reinwein D et al. Testosterone substitution normalizes elevated serum leptin levels in hypogonadal men. Journal of Clinical Endocrinology and Metabolism. 1997;82:2510-2513.
129. Garcia-Mayor RV, Andrade MA, Rios M, Lage M, Dieguez C, Casanueva FF. Serum leptin levels in normal children: relationship to age, gender, body mass index, pituitary-gonadal hormones and pubertal stage. Journal of Clinical Endocrinology and Metabolism. 1997; 82: 2849-2855.
130. Haffner SM, Miettinen H, Karhapa EE, MykkaEnen L, Laakso M. Leptin concentrations, sex hormones, and cortisol in non-diabetic men. Journal of Clinical Endocrinology and Metabolism. 1997; 82: 1807-1809.
131. Janssen J, Huizinga N, Stolk R, Grobbee D, Pols H, de Jong FH et al. The acute effect of dexamethasone on plasma leptin concentrations and the relationships between fasting leptin, the IGF-I/IGF-BP system, dehydro-epiandrosterone, androstenedione and testosterone in an elderly population. Clinical Endocrinology. 1998; 48: 621-626.
132. Grosman H, Fabre B, Lopez M, Scroticati C, Lopez Silva M, Mesch V et al. Complex relationship between sex hormones, insulin resistance and leptin in men with and without prostatic disease. Aging Male. 2016;19(1):40-45.